Page 5 - Pamela Kunz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pamela kunz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pamela Kunz Today - Breaking & Trending Today

Regorafenib: New Option for Advanced Gastroesophageal Cancer?

In patients with advanced refractory gastroesophageal cancer who had tried two other options, regorafenib improved overall survival when compared with placebo, offering a potential new treatment option. ....

New Haven , United States , Merck Serono , Nick Pavlakis , Pamela Kunz , Bristol Myers Squibb , Yale Cancer Center , Boehringer Ingelheim , Merck Kga , Merck Kgaa , Intestinal Trials Group , Royal North Shore Hospital , Gastrointestinal Cancers Symposium , Gastrointestinal Cancers , Smilow Cancer Hospital , Australasian Gastro Intestinal Trials , Merck Sharp , Cancers Symposium , Noncolorectal Gastrointestinal Cancer , Oncolorectal Gi Cancer , Alignant Neoplasia , Colorectal Cancer , Hepatocellular Carcinoma , Liver Cancer , Hepatocellular Cancer , Ancer Liver ,

Women Missing Out on Opportunities From Advisory Boards

Serving on an industry advisory board offers opportunities to influence clinical research, which in turn can boost an academic career, but a recent analysis found that few women have a seat at this table. ....

Pamela Kunz , Rachna Shroff , Division Of Hematology Oncology , University Of Arizona Cancer Center , Yale Cancer Center , Clinical Oncology , Uarizona Cancer Center , Gastrointestinal Cancers , Smilow Cancer Hospital , Clinical Research , Clinical Trials , Linical Studies , Alignant Neoplasia , Professional Development , Clinical Guidelines ,

WHRY Funds Studies on Sex Differences in Treating Gastrointestinal Cancers, Bone Health in Transgender Youth, and the Greater Risk for Alzheimer's Disease in Women < Biological & Biomedical Sciences

Women’s Health Research at Yale today announced funding for three new studies. ....

United States , Pamela Kunz , Carolynm Mazure , Thomasc Naratil , Carolyn Anne Fredericks , Stuart Weinzimer , Women Health Research At Yale , Yale School Of Medicine , Bone Health In Transgender Youth , Yale Cancer Center , Yale Pediatrics Gender Program , Health Research , Pioneer Award , Yale School , Gastrointestinal Cancers , Smilow Cancer Hospital , Yale Cancer , Trevor Project , Pediatrics Gender Program , Todd Constable ,

WHRY Funds Studies on Sex Differences in Treating Gastrointestinal Cancers, Bone Health in Transgender Youth, and the Greater Risk for Alzheimer's Disease in Women < Women's Health Research at Yale

Women’s Health Research at Yale today announced funding for three new studies. ....

United States , Pamela Kunz , Carolynm Mazure , Thomasc Naratil , Carolyn Anne Fredericks , Stuart Weinzimer , Women Health Research At Yale , Yale School Of Medicine , Bone Health In Transgender Youth , Yale Cancer Center , Yale Pediatrics Gender Program , Health Research , Pioneer Award , Yale School , Gastrointestinal Cancers , Smilow Cancer Hospital , Yale Cancer , Trevor Project , Pediatrics Gender Program , Todd Constable ,

Researchers find drug combination shows promise for treating pancreatic neuroendocrine tumors

Patients with advanced pancreatic neuroendocrine tumours (NETs) have few treatment options, but researchers at Yale Cancer Center and Yale-New Haven Health s Smilow Cancer Hospital discovered that patients who received a combination of capecitabine and temozolomide had a higher progression-free survival rate than those who received temozolomide alone. ....

United States , Pamela Kunz , Yale School Of Medicine , National Cancer Institute , Yale New Haven Health Smilow Cancer Hospital , National Clinical Trial Network , Yale Cancer Center , Yale New Haven Health , Smilow Cancer Hospital , American Society , Clinical Oncology , Yale School , Gastrointestinal Cancers , National Clinical Trial , Ews India ,